Literature DB >> 16821705

Biology of the pathogenic yeast Candida glabrata.

A Bialková1, J Subík.   

Abstract

The yeasts, being favorite eukaryotic microorganisms used in food industry and biotechnologies for production of biomass and various substances, are also used as model organisms in genetic manipulation, molecular and biological research. In this respect, Saccharomyces cerevisiae is the best-known species but current situation in medicine and industry requires the use of other species. Here we summarize the basic taxonomic, morphological, physiological, genetic, etc. information about the pathogenic yeast Candida glabrata that is evolutionarily very closely related to baker's yeast.

Entities:  

Mesh:

Year:  2006        PMID: 16821705     DOI: 10.1007/bf02931443

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  144 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.

Authors:  M A Pfaller; D J Diekema; L Boyken; S A Messer; S Tendolkar; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 3.  Yeast chromosome replication and segregation.

Authors:  C S Newlon
Journal:  Microbiol Rev       Date:  1988-12

4.  Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.

Authors:  P Buzzini; A Martini
Journal:  Med Mycol       Date:  2001-12       Impact factor: 4.076

5.  Depletion of the squalene synthase (ERG9) gene does not impair growth of Candida glabrata in mice.

Authors:  H Nakayama; M Izuta; N Nakayama; M Arisawa; Y Aoki
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

6.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

7.  In-vivo selection of an azole-resistant petite mutant of Candida glabrata.

Authors:  Jean-Philippe Bouchara; Rachid Zouhair; Sandrine LE Boudouil; Gilles Renier; Robert Filmon; Dominique Chabasse; Jean-Noel Hallet; Alain Defontaine
Journal:  J Med Microbiol       Date:  2000-11       Impact factor: 2.472

8.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

Review 9.  Transcriptional control of multidrug resistance in the yeast Saccharomyces.

Authors:  W Scott Moye-Rowley
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003

10.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more
  15 in total

1.  Prion-forming ability of Ure2 of yeasts is not evolutionarily conserved.

Authors:  Herman K Edskes; Abbi Engel; Lindsay M McCann; Andreas Brachmann; Huei-Fung Tsai; Reed B Wickner
Journal:  Genetics       Date:  2011-03-02       Impact factor: 4.562

2.  Oxidative stress response and virulence factors in Candida glabrata clinical isolates.

Authors:  N Berila; P Hyroššová; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2011-03-18       Impact factor: 2.099

3.  Molecular analysis of Candida glabrata clinical isolates.

Authors:  Norbert Berila; Julius Subik
Journal:  Mycopathologia       Date:  2010-03-17       Impact factor: 2.574

4.  Mitochondrial DNA heteroplasmy in Candida glabrata after mitochondrial transformation.

Authors:  Jingwen Zhou; Liming Liu; Jian Chen
Journal:  Eukaryot Cell       Date:  2010-03-05

5.  Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata.

Authors:  Monika Batova; Silvia Borecka-Melkusova; Maria Simockova; Vladimira Dzugasova; Eduard Goffa; Julius Subik
Journal:  Curr Genet       Date:  2008-03-15       Impact factor: 3.886

Review 6.  Transcriptional regulators of seven yeast species: comparative genome analysis. Review.

Authors:  E Drobná; A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2008-08-31       Impact factor: 2.099

7.  Molecular and phenotypic analysis of mutations causing anionic phospholipid deficiency in closely related yeast species.

Authors:  M Batová; V Dzugasová; S Borecká; E Goffa; Z Oblasová; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2009-03-29       Impact factor: 2.099

8.  Decreased susceptibility to antifungals in respiratory-deficient Kluyveromyces lactis mutants.

Authors:  M Sarinová; V Straková; K Balková; Y Gbelská
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

9.  Effect of subinhibitory concentration of some established and experimental antifungal compounds on the germ tube formation in Candida albicans.

Authors:  L A Vale-Silva; V Buchta; E Valentová
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

Review 10.  Candidiasis--do we need to fight or to tolerate the Candida fungus?

Authors:  M Raska; J Bĕláková; M Krupka; E Weigl
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.